Arrogene Funding & Investors
Arrogene is a developer of a cancer medical technology designed to create a new generation of nano agents capable of delivering peptide, protein, and oligonucleotide therapeutics across the blood-brain barrier. The company's technology offers a unique nano-medicine platform that delivers multiple tumor inhibitors or imaging agents and is being tailored to fight different types of cancer, enabling patients to prevent tumor growth for imaging.
arrogene.comTotal Amount Raised: $7,898,323
Arrogene Funding Rounds
Series Unknown
$3,232,973
Debt Financing
$750,000
Debt Financing
$250,000
Debt Financing
$170,000
Series Unknown
$2,272,250
Debt Financing
$496,550
Series Unknown
$726,550
Funding info provided by Diffbot.